Saturday, June 25, 2022

Eshelman’s latest investment success

G1 Therapeutics, North Carolina’s newest public company, is off to a strong start after raising $105 million at an initial price of $15 on May 16. To no one’s surprise, Wilmington investor Fred Eshelman is one of the big winners.

Shares of the Research Triangle Park-based company, which is developing anti-cancer drugs, closed today at $16.57 and now has a market value of $454 million, according to The company had net losses of $54 million in 2015-16 with total revenue of $522,000.

Eshelman Ventures, run by the investor whose past successes include PPD and Furiex, owns about 12%, a stake valued at more than $50 million. The fund had put up about $17.5 million in 2015-16, according to a filing. Durham-based Hatteras Venture Partners is the biggest holder with 15.2%.

Eshelman, who graduated from UNC Chapel Hill’s pharmacy school in 1972, has pledged $100 million to his alma mater.

He’s had less success at Valeant Pharmaceuticals, where he joined the board in March 2016 amid a reorganization of the scandal-plagued company. Shares of Valeant have declined by more than 50% since then.




Novant wants to take on Mission/HCA

State Treasurer Dale Folwell lowered the boom against the state’s hospital industry again Tuesday, criticizing them for making too much money and not offering enough charity care. He issued a detailed report on the finances...

Election experts’ $200,000 bill irks some N.C. lawmakers

The latest battle in the redistricting lawsuit is over who should pay the roughly $200,000 bill from the special masters who redrew congressional maps at the court’s request. The advocacy groups that filed the initial...

First Bank parent buying South Carolina bank for $181M

First Bancorp pushes deeper into South Carolina
house neighborhood

Realtor leaders expect slower, but still vital housing market

We are in a strange real estate market, those of us who live in metropolitan areas. Prices have been going up, homes have been getting multiple offers and they haven’t stayed on the market...
Truck toll system, german highway - control gantry, some minor motion blurring

Is tolling ahead for Charlotte’s South I-77?

Someone wants to add toll lanes to the often-congested stretch of Interstate 77 between center-city Charlotte and the South Carolina state line. But that party doesn’t want its name in the public yet. So...
David Mildenberg
David Mildenberg is editor of Business North Carolina. Reach him at

Related Articles